当前位置: X-MOL 学术Bipolar Disord. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antidepressant monotherapy in treatment‐refractory bipolar II depression
Bipolar Disorders ( IF 5.4 ) Pub Date : 2024-03-14 , DOI: 10.1111/bdi.13419
Takeshi Terao 1
Affiliation  

CONFLICT OF INTEREST STATEMENT

Interests from the past 3 years are as follows. Dr. Terao received speaker's honoraria from Sumitomo Pharma, Shionogi, Otsuka, Eisai, Daiichi Sankyo, Janssen, Viatris, Takeda, Meiji, Mochida, MSD, and Tanabe-Mitsubishi (Yoshitomi).



中文翻译:

抗抑郁单一疗法治疗难治性双相 II 型抑郁症

利益冲突声明

过去3年的兴趣如下。Terao 博士获得了住友制药、盐野木、大冢、卫材、第一三共、杨森、Viatris、武田、明治、持田、默沙东和田边三菱 (Yoshitomi) 的演讲者酬金。

更新日期:2024-03-14
down
wechat
bug